Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

SHFS vs IIPR vs SAFE vs LGND

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SHFS
SHF Holdings, Inc.

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$1M
5Y Perf.-99.8%
IIPR
Innovative Industrial Properties, Inc.

REIT - Industrial

Real EstateNYSE • US
Market Cap$1.62B
5Y Perf.-77.0%
SAFE
Safehold Inc.

REIT - Diversified

Real EstateNYSE • US
Market Cap$1.11B
5Y Perf.-82.8%
LGND
Ligand Pharmaceuticals Incorporated

Biotechnology

HealthcareNASDAQ • US
Market Cap$4.13B
5Y Perf.+59.0%

SHFS vs IIPR vs SAFE vs LGND — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SHFS logoSHFS
IIPR logoIIPR
SAFE logoSAFE
LGND logoLGND
IndustryBanks - RegionalREIT - IndustrialREIT - DiversifiedBiotechnology
Market Cap$1M$1.62B$1.11B$4.13B
Revenue (TTM)$18M$263M$386M$251M
Net Income (TTM)$-53M$120M$114M$49M
Gross Margin104.7%60.3%97.7%85.9%
Operating Margin-24.2%46.7%39.8%7.0%
Forward P/E13.2x9.1x23.6x
Total Debt$12M$394M$4.49B$7M
Cash & Equiv.$2M$48M$22M$72M

SHFS vs IIPR vs SAFE vs LGNDLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SHFS
IIPR
SAFE
LGND
StockAug 21May 26Return
SHF Holdings, Inc. (SHFS)1000.2-99.8%
Innovative Industri… (IIPR)10023.0-77.0%
Safehold Inc. (SAFE)10017.2-82.8%
Ligand Pharmaceutic… (LGND)100159.0+59.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: SHFS vs IIPR vs SAFE vs LGND

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: IIPR leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Ligand Pharmaceuticals Incorporated is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. SAFE also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
SHFS
SHF Holdings, Inc.
The Financial Play

SHFS lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: financial services exposure
IIPR
Innovative Industrial Properties, Inc.
The Real Estate Income Play

IIPR carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 9 yrs, beta 0.92, yield 13.5%
  • 436.4% 10Y total return vs LGND's 73.0%
  • Lower volatility, beta 0.92, Low D/E 21.3%, current ratio 0.15x
  • Beta 0.92, yield 13.5%, current ratio 0.15x
Best for: income & stability and long-term compounding
SAFE
Safehold Inc.
The Real Estate Income Play

SAFE is the clearest fit if your priority is growth exposure and valuation efficiency.

  • Rev growth 5.4%, EPS growth 7.4%, 3Y rev CAGR 12.6%
  • PEG 1.44 vs IIPR's 3.52
  • Lower P/E (9.1x vs 23.6x)
Best for: growth exposure and valuation efficiency
LGND
Ligand Pharmaceuticals Incorporated
The Growth Leader

LGND is the #2 pick in this set and the best alternative if growth and momentum is your priority.

  • 27.3% revenue growth vs IIPR's -13.8%
  • +99.1% vs SHFS's -81.8%
Best for: growth and momentum
See the full category breakdown
CategoryWinnerWhy
GrowthLGND logoLGND27.3% revenue growth vs IIPR's -13.8%
ValueSAFE logoSAFELower P/E (9.1x vs 23.6x)
Quality / MarginsIIPR logoIIPR45.6% margin vs SHFS's -262.5%
Stability / SafetyIIPR logoIIPRBeta 0.92 vs SHFS's 1.87
DividendsIIPR logoIIPR13.5% yield, 9-year raise streak, vs SAFE's 4.6%, (2 stocks pay no dividend)
Momentum (1Y)LGND logoLGND+99.1% vs SHFS's -81.8%
Efficiency (ROA)IIPR logoIIPR5.1% ROA vs SHFS's -389.6%, ROIC 4.3% vs -13.7%

SHFS vs IIPR vs SAFE vs LGND — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SHFSSHF Holdings, Inc.

Segment breakdown not available.

IIPRInnovative Industrial Properties, Inc.

Segment breakdown not available.

SAFESafehold Inc.

Segment breakdown not available.

LGNDLigand Pharmaceuticals Incorporated
FY 2024
Royalty
27.9%$109M
Intangible Royalty Assets
24.4%$95M
Royalty, Kyprolis
9.8%$38M
Material Sales, Captisol, Core
7.9%$31M
Material Sales, Captisol
7.9%$31M
Contract Revenue
7.0%$27M
Service
6.5%$26M
Other (4)
8.5%$33M

SHFS vs IIPR vs SAFE vs LGND — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLIIPRLAGGINGSHFS

Income & Cash Flow (Last 12 Months)

IIPR leads this category, winning 3 of 6 comparable metrics.

SAFE is the larger business by revenue, generating $386M annually — 20.9x SHFS's $18M. IIPR is the more profitable business, keeping 45.6% of every revenue dollar as net income compared to SHFS's -2.6%. On growth, LGND holds the edge at +122.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSHFS logoSHFSSHF Holdings, Inc.IIPR logoIIPRInnovative Indust…SAFE logoSAFESafehold Inc.LGND logoLGNDLigand Pharmaceut…
RevenueTrailing 12 months$18M$263M$386M$251M
EBITDAEarnings before interest/tax-$11M$197M$163M$52M
Net IncomeAfter-tax profit-$53M$120M$114M$49M
Free Cash FlowCash after capex-$5M$144M$48M$31M
Gross MarginGross profit ÷ Revenue+104.7%+60.3%+97.7%+85.9%
Operating MarginEBIT ÷ Revenue-24.2%+46.7%+39.8%+7.0%
Net MarginNet income ÷ Revenue-2.6%+45.6%+29.7%+19.3%
FCF MarginFCF ÷ Revenue+2.3%+54.7%+12.4%+12.2%
Rev. Growth (YoY)Latest quarter vs prior year-3.8%+6.5%+122.8%
EPS Growth (YoY)Latest quarter vs prior year-53.8%-1.0%+8.3%+15.6%
IIPR leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

SAFE leads this category, winning 3 of 7 comparable metrics.

At 9.7x trailing earnings, SAFE trades at a 33% valuation discount to IIPR's 14.4x P/E. Adjusting for growth (PEG ratio), SAFE offers better value at 1.53x vs IIPR's 3.85x — a lower PEG means you pay less per unit of expected earnings growth.

MetricSHFS logoSHFSSHF Holdings, Inc.IIPR logoIIPRInnovative Indust…SAFE logoSAFESafehold Inc.LGND logoLGNDLigand Pharmaceut…
Market CapShares × price$1M$1.6B$1.1B$4.1B
Enterprise ValueMkt cap + debt − cash$11M$2.0B$5.6B$4.1B
Trailing P/EPrice ÷ TTM EPS-0.03x14.40x9.70x-956.05x
Forward P/EPrice ÷ next-FY EPS est.13.17x9.09x23.65x
PEG RatioP/E ÷ EPS growth rate3.85x1.53x
EV / EBITDAEnterprise value multiple9.91x17.64x322.10x
Price / SalesMarket cap ÷ Revenue0.07x6.08x2.87x24.74x
Price / BookPrice ÷ Book value/share0.87x0.45x4.63x
Price / FCFMarket cap ÷ FCF3.15x9.26x23.16x53.41x
SAFE leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

LGND leads this category, winning 5 of 9 comparable metrics.

IIPR delivers a 6.4% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $-8 for SHFS. LGND carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to SAFE's 1.84x. On the Piotroski fundamental quality scale (0–9), LGND scores 5/9 vs SAFE's 4/9, reflecting solid financial health.

MetricSHFS logoSHFSSHF Holdings, Inc.IIPR logoIIPRInnovative Indust…SAFE logoSAFESafehold Inc.LGND logoLGNDLigand Pharmaceut…
ROE (TTM)Return on equity-7.6%+6.4%+4.7%+5.1%
ROA (TTM)Return on assets-3.9%+5.1%+1.6%+3.3%
ROICReturn on invested capital-13.7%+4.3%+3.4%-2.3%
ROCEReturn on capital employed-13.1%+5.8%+4.4%-2.7%
Piotroski ScoreFundamental quality 0–94445
Debt / EquityFinancial leverage0.21x1.84x0.01x
Net DebtTotal debt minus cash$10M$346M$4.5B-$65M
Cash & Equiv.Liquid assets$2M$48M$22M$72M
Total DebtShort + long-term debt$12M$394M$4.5B$7M
Interest CoverageEBIT ÷ Interest expense-17.46x6.67x1.57x22.69x
LGND leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

LGND leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in LGND five years ago would be worth $16,102 today (with dividends reinvested), compared to $24 for SHFS. Over the past 12 months, LGND leads with a +99.1% total return vs SHFS's -81.8%. The 3-year compound annual growth rate (CAGR) favors LGND at 39.5% vs SHFS's -64.1% — a key indicator of consistent wealth creation.

MetricSHFS logoSHFSSHF Holdings, Inc.IIPR logoIIPRInnovative Indust…SAFE logoSAFESafehold Inc.LGND logoLGNDLigand Pharmaceut…
YTD ReturnYear-to-date-55.3%+18.3%+14.4%+10.6%
1-Year ReturnPast 12 months-81.8%+20.3%+1.1%+99.1%
3-Year ReturnCumulative with dividends-95.4%+14.1%-37.3%+171.6%
5-Year ReturnCumulative with dividends-99.8%-50.0%-71.0%+61.0%
10-Year ReturnCumulative with dividends-99.8%+436.4%-50.3%+73.0%
CAGR (3Y)Annualised 3-year return-64.1%+4.5%-14.4%+39.5%
LGND leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

IIPR leads this category, winning 2 of 2 comparable metrics.

IIPR is the less volatile stock with a 0.92 beta — it tends to amplify market swings less than SHFS's 1.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IIPR currently trades 92.2% from its 52-week high vs SHFS's 5.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSHFS logoSHFSSHF Holdings, Inc.IIPR logoIIPRInnovative Indust…SAFE logoSAFESafehold Inc.LGND logoLGNDLigand Pharmaceut…
Beta (5Y)Sensitivity to S&P 5001.87x0.92x0.96x0.99x
52-Week HighHighest price in past year$9.19$61.40$17.16$247.38
52-Week LowLowest price in past year$0.38$44.58$12.76$98.89
% of 52W HighCurrent price vs 52-week peak+5.1%+92.2%+89.9%+85.0%
RSI (14)Momentum oscillator 0–10045.459.349.859.3
Avg Volume (50D)Average daily shares traded270K303K333K226K
IIPR leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

IIPR leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: IIPR as "Hold", SAFE as "Buy", LGND as "Buy". Consensus price targets imply 27.3% upside for LGND (target: $268) vs -22.3% for IIPR (target: $44). For income investors, IIPR offers the higher dividend yield at 13.46% vs SAFE's 4.60%.

MetricSHFS logoSHFSSHF Holdings, Inc.IIPR logoIIPRInnovative Indust…SAFE logoSAFESafehold Inc.LGND logoLGNDLigand Pharmaceut…
Analyst RatingConsensus buy/hold/sellHoldBuyBuy
Price TargetConsensus 12-month target$44.00$14.00$267.75
# AnalystsCovering analysts111717
Dividend YieldAnnual dividend ÷ price+13.5%+4.6%
Dividend StreakConsecutive years of raises941
Dividend / ShareAnnual DPS$7.62$0.71
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.2%0.0%0.0%
IIPR leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

IIPR leads in 3 of 6 categories (Income & Cash Flow, Risk & Volatility). LGND leads in 2 (Profitability & Efficiency, Total Returns).

Best OverallInnovative Industrial Prope… (IIPR)Leads 3 of 6 categories
Loading custom metrics...

SHFS vs IIPR vs SAFE vs LGND: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SHFS or IIPR or SAFE or LGND a better buy right now?

For growth investors, Ligand Pharmaceuticals Incorporated (LGND) is the stronger pick with 27.

3% revenue growth year-over-year, versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). Safehold Inc. (SAFE) offers the better valuation at 9. 7x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate Safehold Inc. (SAFE) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SHFS or IIPR or SAFE or LGND?

On trailing P/E, Safehold Inc.

(SAFE) is the cheapest at 9. 7x versus Innovative Industrial Properties, Inc. at 14. 4x. On forward P/E, Safehold Inc. is actually cheaper at 9. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Safehold Inc. wins at 1. 44x versus Innovative Industrial Properties, Inc. 's 3. 52x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — SHFS or IIPR or SAFE or LGND?

Over the past 5 years, Ligand Pharmaceuticals Incorporated (LGND) delivered a total return of +61.

0%, compared to -99. 8% for SHF Holdings, Inc. (SHFS). Over 10 years, the gap is even starker: IIPR returned +436. 4% versus SHFS's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SHFS or IIPR or SAFE or LGND?

By beta (market sensitivity over 5 years), Innovative Industrial Properties, Inc.

(IIPR) is the lower-risk stock at 0. 92β versus SHF Holdings, Inc. 's 1. 87β — meaning SHFS is approximately 105% more volatile than IIPR relative to the S&P 500. On balance sheet safety, Ligand Pharmaceuticals Incorporated (LGND) carries a lower debt/equity ratio of 1% versus 184% for Safehold Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — SHFS or IIPR or SAFE or LGND?

By revenue growth (latest reported year), Ligand Pharmaceuticals Incorporated (LGND) is pulling ahead at 27.

3% versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). On earnings-per-share growth, the picture is similar: Safehold Inc. grew EPS 7. 4% year-over-year, compared to -114. 7% for SHF Holdings, Inc.. Over a 3-year CAGR, SAFE leads at 12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SHFS or IIPR or SAFE or LGND?

Innovative Industrial Properties, Inc.

(IIPR) is the more profitable company, earning 43. 0% net margin versus -262. 5% for SHF Holdings, Inc. — meaning it keeps 43. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SAFE leads at 79. 8% versus -24. 2% for SHFS. At the gross margin level — before operating expenses — SHFS leads at 104. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SHFS or IIPR or SAFE or LGND more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Safehold Inc. (SAFE) is the more undervalued stock at a PEG of 1. 44x versus Innovative Industrial Properties, Inc. 's 3. 52x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Safehold Inc. (SAFE) trades at 9. 1x forward P/E versus 23. 6x for Ligand Pharmaceuticals Incorporated — 14. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LGND: 27. 3% to $267. 75.

08

Which pays a better dividend — SHFS or IIPR or SAFE or LGND?

In this comparison, IIPR (13.

5% yield), SAFE (4. 6% yield) pay a dividend. SHFS, LGND do not pay a meaningful dividend and should not be held primarily for income.

09

Is SHFS or IIPR or SAFE or LGND better for a retirement portfolio?

For long-horizon retirement investors, Innovative Industrial Properties, Inc.

(IIPR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 92), 13. 5% yield, +436. 4% 10Y return). SHF Holdings, Inc. (SHFS) carries a higher beta of 1. 87 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IIPR: +436. 4%, SHFS: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SHFS and IIPR and SAFE and LGND?

These companies operate in different sectors (SHFS (Financial Services) and IIPR (Real Estate) and SAFE (Real Estate) and LGND (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SHFS is a small-cap quality compounder stock; IIPR is a small-cap deep-value stock; SAFE is a small-cap deep-value stock; LGND is a small-cap high-growth stock. IIPR, SAFE pay a dividend while SHFS, LGND do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SHFS

Quality Business

  • Sector: Financial Services
  • Market Cap > $100B
  • Gross Margin > 62%
Run This Screen
Stocks Like

IIPR

Dividend Mega-Cap Quality

  • Sector: Real Estate
  • Market Cap > $100B
  • Net Margin > 27%
  • Dividend Yield > 5.3%
Run This Screen
Stocks Like

SAFE

Dividend Mega-Cap Quality

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 17%
Run This Screen
Stocks Like

LGND

High-Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 61%
  • Net Margin > 11%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SHFS and IIPR and SAFE and LGND on the metrics below

Revenue Growth>
%
(SHFS: -9.2% · IIPR: -3.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.